Skip to main content
Premium Trial:

Request an Annual Quote

Leslie Kirwan, Joshua Boger, Peter Slavin, Lydia Villa-Komaroff, Daniel O’Connell, Marc Beer, Jack Wilson, Jay Gonzalez, Micheline Mathews-Roth, Chris Camacho

Premium
Mass. Life Sciences Center Names New Seven-Member Board Wrought by Biotech Bill
 
A month after signing into law a $1 billion, 10-year life sciences initiative, Massachusetts Gov. Deval Patrick has named the members of the new seven-person board for the agency charged with overseeing how the money is spent, as well as the state’s overall life-sciences effort.
 
At its last meeting July 23, the Massachusetts Life Sciences Center welcomes four newcomers to a board of directors that retains three holdover members from the old board, appointed before Patrick signed the life-sci act on June 16.
 
Joining the life sciences center board:
  • Leslie Kirwan, Massachusetts secretary of administration and finance, and one of two co-chairs of the new board.
  • Joshua Boger, president and CEO of Vertex Pharmaceuticals.
  • Peter Slavin, president of Massachusetts General Hospital.
  • Lydia Villa-Komaroff, CEO of Cytonome.
The four fulfill a requirement in the initiative that the board include a physician licensed to practice medicine in the commonwealth and affiliated with an academic medical center; a CEO of a Massachusetts-based life sciences corporation that is a member of the board of directors of the Massachusetts Biotechnology Council; a researcher “involved in the commercialization of biotechnology, pharmaceuticals or medical diagnostic products;” and a professional with “significant financial experience in the life-sciences sector.”
 
The four join Daniel O’Connell, the other co-chair and the state’s secretary of housing and economic development; Marc Beer, former CEO of ViaCell; and Jack Wilson, president of the University of Massachusetts. O’Connell had chaired the center’s former five-member board
 
In addition to O’Connell, Beer, and Wilson, the former board included Jay Gonzalez, the state’s undersecretary of administration and finance; and Micheline Mathews-Roth, a professor of medicine at Harvard Medical School, and an associate physician at Brigham and Women's Hospital.
 

 
Yuma Economic Development Leader Joins GPEC As Business Development VP
 
Chris Camacho has joined the Greater Phoenix Economic Council as vice president of business development. Camacho’s duties include expanding GPEC’s business attraction efforts in emerging technology and international economic development.
 
Camacho previously was president and CEO of the Greater Yuma Economic Development Corporation. During his three and a half year tenure, GYEDC assisted in relocating to Greater Yuma 35 companies bringing more than 3,500 new manufacturing and service jobs, and generating $450 million in new capital investment. 
 
“In my new role a primary focus is to develop and deploy strategies to expand bioscience, solar and healthcare companies to Greater Phoenix,” Camacho said in a press release announcing his new appointment.
 
Before moving to Arizona in 2004, Camacho held positions with TheAlliance, a regional economic development organization in Greater St. Louis; and also served as an economic development finance consultant for Madison County, Ill.
 
Camacho earned a masters degree in public administration and public policy at Southern Illinois University, where he also studied psychology and business administration as an undergraduate. He also completed the Economic Development Institute at the University of Oklahoma.
 
GPEC is a public-private regional economic development organization that joins 18 member communities, Arizona’s Maricopa County, and more than 140 private investors.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.